31 van Rood YR, van Hemert BJ, Merkelbach J, Colijn S, Kasius M, Oudshoorn M, et al. Zorgprogramma somatoforme en aanverwante stoornissen: stepped-care richtlijnen voor evidence-based behandeling; 2002. 32 Kroenke KRS. Cognitive-Behavioral Therapy for Somatization and Symptom Syndromes: A Critical Review of Controlled Clinical Trials. Psychother Psychosom 2000;69:205-15. 33 Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005;331:435-441. 34 Noorthoorn van der Kruijff EO, De Haan HA, Van Stiphout WAHJ, Havelaar JM. Berichten uit de zorg. Eindrapport onderzoek onder volwassenen in behandeling bij Mediant Nazorg Vuurwerkramp. Twente: Geestelijke Gezondheidszorg, 2006. 35 Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatique syndrome: A randomized controlled trial. American Journal of Preventive Medicine 1997;154:408-414. 36 Keefe FJ. Cognitive behavioural therapy for managing pain. Clin Psychol 1996;49:4-5. 37 Sharpe M, Hawton K, Simkin S, et.al. Cognitive behavioural therapy for the chronic fatique syndrome: a randomized controlles trial. BMJ 1996;312:22-26. 38 Donta S, Engel CC, et.al. Cognitive Behavioral Therapy and Aerobic Exercise for Gulf War Veterans' illnesses. JAMA 2003;289:1396-1404. 39 Chisholm D, Godfrey E, Ridsdale L, Chalder T, King M, Seed P, et al. Chronic fatique in general practice: economic evaluation of counseling versus cognitive behaviour therapy. British Journal of General Practice 2001;51:15-18. 40 Hiller W, Fichter MM, Rief W. A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res 2003;54:369-380. 41 Severens JL, Prins JB, van der Wilt GJ, Van der Meer JWM, Bleijenberg G. Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatique syndrome. Q J Med 2004;97:153-161. 42 Morris R, Gask L, Ronalds C, Downes-Grainger E, Thompson H, Leese B, et al. Cost-effectiveness of a new treatment for somatized mental disorder taught to GP's. Family Practice-an international journal 1998;15(2):119- 25. 43 Van Rood Y, Ouwehand A. Het gebruik van ontspanningsoefeningen bij patiënten die zijn <strong>op</strong>genomen voor een somatische aandoening. Directieve Therapie 2001; 147-158. 44 Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JW. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001;357:841-7. 45 Bazelmans E, Prins JB, Lulofs R, van der Meer JW, Bleijenberg G; The Netherlands Fatigue Research Group Nijmegen. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. Psychother Psychosom 2005;74:218-24. 46 NICE. National Institute for Health and Clinical Excellence (UK) www.nice.org.uk. 47 Speckens AEM, Van Hemert AM, Bolk JH, Hawton KE & Rooijmans HGM. The Acceptability of Psychological Treatment in Patients with Medically Unexplained Physical Symptoms. Journal of Psychosomatic Research 1995;39:855-863. 48 Gezondheidsraad. Gevolgen van rampen voor de gezondheid <strong>op</strong> middellange en lange termijn. Den Haag: Gezondheidsraad, 2006. Referentie in bijlage 1 en 2, aanvullend <strong>op</strong> bovenstaande referenties xlix Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain 2002; 18: 324-36. l O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48:980-90. li O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 2000;15:659-66. lii Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum 2004;51:9-13. liii Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP Jr, LaMoreaux LK, Martin SA, Sharma U; Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73. liv Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, Hoofs MP, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347:858-61. lv Powell P, Bentall RP, Nye FJ, Edwards RH. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ 2001;322:387-90. lvi Powell P, Bentall RP, Nye FJ, Edwards RH. Patient education to encourage graded exercise in chronic fatigue syndrome. 2-year follow-up of randomised controlled trial. Br J Psychiatry 2004;184:142-6. lvii Deale A, Husain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry 2001;158:2038-42. <strong>Zicht</strong> <strong>op</strong> Lok 32
lviii Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol 2004;72:1100-13. lix Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003;15:79-86. lx Van der Veek PP, van Rood YR, Masclee AA. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 943-52. lxi Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2004;(1):CD003960. lxii Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:355-61. lxiii Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther 2005;22:381-5. lxiv van Peski-Oosterbaan AS, Spinhoven P, van Rood Y, van der Does JW, Bruschke AV, Rooijmans HG. Cognitive-behavioral therapy for noncardiac chest pain: a randomized trial. Am J Med 1999;106:424-9. lxv Speckens AEM, Spinhoven P, van Rood YR. Protocollaire behandeling van patiënten met onverklaarde lichamelijke klachten: Cognitieve gedragstherapie. In: Keijsers GPJ, van Minnen A, Hoogduin CAL, editors. Protocollaire behandelingen in de ambulante geestelijke gezondheidszorg. Houten/Diegem: Bohn Stafleu Van Loghum; 1999. lxvi MacLeod AK, Haynes C, Sensky T. Attributions about common bodily sensations: Their associations with hypochondriasis and anxiety. Psychol Med 1998;28:225-228. lxvii Sumathipala A, S. H, R. H, Mann AH. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: A feasibility study in Sri Lanka. Psychol Med 2000;30:747- 757. lxviii Blankenstein AH. Somatising patients in general practice. Reattrubution, a promising approach. Amsterdam: Vrije Universiteit Amsterdam, 2001. <strong>Zicht</strong> <strong>op</strong> <strong>LOK</strong> 33